CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Edwards Lifesciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Edwards Lifesciences Corp
One Edwards Way
Phone: (949) 250-2500p:949 250-2500 IRVINE, CA  92614  United States Ticker: EWEW

Business Summary
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202412/31/2024YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Nicholas J.Valeriani 68 5/7/2024 11/13/2014
Chief Executive Officer, Director Bernard J.Zovighian 57 5/1/2023 1/1/2016
Chief Financial Officer, Corporate Vice President Scott B.Ullem 58 1/2/2014 1/2/2014
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Valtech Cardio Ltd. 6 Yoni Netanyahu St' Or Yehuda Israel
Innovalve Bio Medical Ltd Sheba Medical Center Tel Hashomer Israel
Bmeye B.V. Academic Medical Center Meibergdreef 9 Amsterdam Netherlands
5 additional Subsidiary records available in full report.

Business Names
Business Name
CardiAQ Valve Technologies, Inc.
CAS Medical Systems Inc
Edwards Lifesciences (Japan) Inc.
5 additional Business Names available in full report.

General Information
Number of Employees: 15,800 (As of 12/31/2024)
Outstanding Shares: 587,900,000 (As of 1/31/2025)
Shareholders: 7,197
Stock Exchange: NYSE
Federal Tax Id: 364316614
Fax Number: (302) 655-5049
Email Address: investor_relations@edwards.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 11, 2025